Search Result "Systemic mastocytosis"
Interferon-α Treatment in Systemic Mastocytosis
Journal: Current Drug Targets
Volume: 12 Issue: 3 Year: 2011 Page: 433-436
Author(s): Ole Weis Bjerrum
Kit: Molecule of Interest for the Diagnosis and Treatment of Mastocytosis and other Neoplastic Disorders
Journal: Current Cancer Drug Targets
Volume: 7 Issue: 5 Year: 2007 Page: 492-503
Author(s): Mrinal M. Patnaik, Ayalew Tefferi, Animesh Pardanani
Current Options in the Treatment of Mast Cell Mediator-Related Symptoms in Mastocytosis
Journal: Inflammation & Allergy - Drug Targets (Discontinued)
Volume: 5 Issue: 1 Year: 2006 Page: 61-77
Author(s): Luis Escribano, Cem Akin, Mariana Castells, Lawrence B. Schwartz
Acute Myocardial Infarction in Systemic Mastocytosis: Case Report With Literature Review on the Role of Inflammatory Process in Acute Coronary Syndrome
Journal: Current Cardiology Reviews
Volume: 16 Issue: 4 Year: 2020 Page: 333-337
Author(s): Ayman Battisha,Khalid Sawalha,Bader Madoukh,Omar Sheikh,Karim Doughem,Mohammad Al-Akchar,Mohammed Al-Sadawi,Shakil Shaikh
Mast Cell Disorders In Drug Hypersensitivity
Journal: Current Pharmaceutical Design
Volume: 22 Issue: 45 Year: 2016 Page: 6862-6869
Author(s): Patrizia Bonadonna,Massimiliano Bonifacio,Roberta Zanotti
Mast Cells as Targets of Pimecrolimus
Journal: Current Pharmaceutical Design
Volume: 17 Issue: 3 Year: 2011 Page: 3823-3829
Author(s): Zhongcai Ma, Zongjiu Jiao
The Current Status of Cladribine in the Treatment of Lymphoid and Myeloid Malignancies
Ebook: Frontiers in Clinical Drug Research - Anti-Cancer Agents
Volume: 1 Year: 2013
Author(s): Tadeusz Robak,Pawel Robak
Doi: 10.2174/9781608057986113010004
Anaphylaxis in Risky Populations
Journal: Current Pharmaceutical Design
Volume: 29 Issue: 3 Year: 2023 Page: 224-238
Author(s):
Chronic Myeloproliferative Diseases
Ebook: Physiopathogenesis of Hematological Cancer
Volume: 1 Year: 2012
Author(s): Katia B. Barbosa Pagnano
Doi: 10.2174/978160805259211201010193
Bronchoalveolar Lavage in Hypersensitivity Pneumonitis: A Series of 139 Patients
Journal: Inflammation & Allergy - Drug Targets (Discontinued)
Volume: 11 Issue: 1 Year: 2012 Page: 15-19
Author(s): Denis M. Caillaud, Jean M. Vergnon, Anne Madroszyk, Boris M. Melloni, Marlene Murris, Jean C. Dalphin